Four women receive Brilife COVID vaccination, as Hadassah trials continue

"I have no fear of getting the shot, because I've read up and researched the composition of the vaccine."

25-year-old Sharon Ben Hemo, a fourth-year student at the Faculty of Dentistry of Hadassah and Hebrew University, receives the IIBR's Brilife vaccine as part of the first phase of human trials in Hadassah University Medical Center, 08.11.2020 (photo credit: HADASSAH UNIVERSITY MEDICAL CENTER)
25-year-old Sharon Ben Hemo, a fourth-year student at the Faculty of Dentistry of Hadassah and Hebrew University, receives the IIBR's Brilife vaccine as part of the first phase of human trials in Hadassah University Medical Center, 08.11.2020
(photo credit: HADASSAH UNIVERSITY MEDICAL CENTER)
On Sunday morning, four women who were selected to participate in the human trial of "Brilife," the Israeli Institute for Biological Research's (IIBR) coronavirus vaccine, were vaccinated at Hadassah University Medical Center in Jerusalem's Ein Kerem.
All four women were in their 20s - 30s and had been medically tested and found suitable to participate in the trial, which began last Sunday, and to receive the vaccine. 
They arrived at the Center for Clinical Studies in Humans at Hadassah, where the vaccine was injected into their arms by Nurse Hannah Drori, head of the center's nursing staff. She was accompanied by Prof. Yoseph Caraco, director of the center.
"We are grateful to all of you," Prof. Caraco told the trial's participants after delving into a detailed explanation of the vaccine's contents. 
'Without your willingness to volunteer, it would not have been possible to advance this research and reach the next stages of the trial and begin vaccinating older populations as well. Thanks to you, we will be able to reach the coveted moment of returning to everyday life in Israel," he said.
25-year-old Sharon Ben Hemo, a fourth-year student in the Faculty of Dentistry of Hadassah and Hebrew University, chose to participate and receive the vaccine on Sunday morning.
'I heard about the possibility of participating in the clinical trial through other students and decided to join. I have no fear of getting the shot, because I've read up and researched the composition of the vaccine," she said. 
"I am happy to be part of an important process that should bring the coronavirus to an end," she concluded.